Literature DB >> 6979257

Localization of toxic encephalopathies near lesions of experimental allergic encephalomyelitis.

S Levine, R Sowinski.   

Abstract

Bipiperidyl mustard and a neurotoxic triamine are known to cause edematous and/or necrotizing lesions in particular areas of hypothalamus and dorsal medulla but not in spinal cord. Experimental allergic encephalomyelitis (EAR) causes widespread inflammatory lesions that are especially numerous in spinal cord. When the chemical toxicants were administered to rats during the acute phase of EAE, mortality was increased. This was due to a specific interaction between EAE and chemical toxicants leading to the development of necrotizing vasculitis and parenchymal necrosis near EAE lesions in spinal cord or brain. The interaction decreased as the EAE lesions healed. Another neurotoxic chemical, dipiperidinoethane, did not produce this phenomenon. These effects of EAE are probably related to damage to the vessel walls and the blood-brain barrier. The present work may increase the versatility of EAE as a model for multiple sclerosis if the EAE lesions can be enlarged progressively by repeated exposures to the toxicant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979257      PMCID: PMC1916005     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  A HYPERACUTE FORM OF ALLERGIC ENCEPHALOMYELITIS.

Authors:  S LEVINE; E J WENK
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

2.  A study of abnormal blood-brain permeability in experimental allergic encephalomyelitis.

Authors:  C F BARLOW
Journal:  J Neuropathol Exp Neurol       Date:  1956-04       Impact factor: 3.685

3.  Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis.

Authors:  R K Bergman; J J Munoz; J L Portis
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

Review 4.  Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: a review.

Authors:  S Levine
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

5.  The permeability of the blood-brain barrier to 51Cr-EDTA in rabbits with experimental allergic encephalomyelitis.

Authors:  O Amtorp; S C Sorensen
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

6.  Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis.

Authors:  S Leibowitz; L Kennedy
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

7.  Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.

Authors:  W Stohl; N K Gonatas
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

8.  Disposition and activity in experimental allergic encephalomyelitis of flumizole, a nonacidic, nonsteroidal, anti-inflammatory agent.

Authors:  H M McIlhenny; S Levine; E H Wiseman; R Sowinski
Journal:  Exp Neurol       Date:  1978-01-01       Impact factor: 5.330

9.  Necrotic myelopathy (myelomalacia) in rats with allergic encephalomyelitis treated with tilorone.

Authors:  S Levine; R Sowinski
Journal:  Am J Pathol       Date:  1976-02       Impact factor: 4.307

10.  About demyelinating properties of humoral antibodies in experimental allergic encephalomyelitis. In vivo and in vitro studies.

Authors:  K Kristensson
Journal:  Acta Neuropathol       Date:  1976-12-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.